Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Diane Lauren Reidy is active.

Publication


Featured researches published by Diane Lauren Reidy.


Nature Reviews Clinical Oncology | 2009

Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors

Diane Lauren Reidy; Laura H. Tang; Leonard Saltz

Well-differentiated neuroendocrine tumors (NETs), which are also referred to as well-differentiated endocrine carcinoma according to WHO terminology, are usually slow-growing cancers, even when they exhibit gross local invasion and/or metastases. The survival of patients with metastatic NET is often measured in years to decades. Once NET progresses or becomes symptomatic the patients prognosis is poor. An important challenge for clinicians is to distinguish at an early stage those patients who will die with the disease, from those who will succumb because of it, so that the appropriate level of care can be administered. Reliable genomic predictors could provide substantial advancements in prognosis and, possibly, treatment; however, such markers are currently unavailable. Early literature on the treatment of NETs is confounded by a lack of formal objective response criteria. Somatostatin analogs can control symptoms and can stabilize some slow-growing tumors, but rarely result in tumor regression. Surgery is curative in only a minority of patients, and systemic chemotherapy is minimally effective. Advances in the understanding of tumor biology have led to the identification of important cellular processes involved in the pathogenesis of NETs, and agents that target these processes have now entered clinical trials. We will discuss the data on therapies currently used to treat well-differentiated NETs, and the strategies being used in clinical trials.


Journal of Clinical Oncology | 2010

Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer.

Deborah Schrag; Martin R. Weiser; Karyn A. Goodman; Mithat Gonen; Andrea Cercek; Diane Lauren Reidy; Larissa K. Temple; W. D. Wong; P. Paty; Leonard Saltz


Journal of Clinical Oncology | 2010

Complete pathologic response in the primary of rectal or colon cancer treated with FOLFOX without radiation.

Andrea Cercek; Martin R. Weiser; Karyn A. Goodman; Diane Lauren Reidy; W. D. Wong; Jose G. Guillem; Larissa K. Temple; Deborah Schrag; P. Paty; Leonard Saltz


Journal of Clinical Oncology | 2017

Total neoadjuvant chemotherapy to facilitate delivery and tolerance of systemic chemotherapy and response in locally advanced rectal cancer.

Andrea Cercek; Campbell S. Roxburgh; Paul Strombom; Jesse Joshua Smith; Larissa K. Temple; Garrett M. Nash; Jose G. Guillem; Philip B. Paty; Rona Yaeger; Zsofia K. Stadler; Neil Howard Segal; Diane Lauren Reidy; Jinru Shia; Efsevia Vakiani; Abraham J. Wu; Christopher H. Crane; Marc J. Gollub; Julio Garcia-Aguilar; Leonard Saltz; Martin R. Weiser


Journal of Clinical Oncology | 2011

Incidence of FOLFOX induced amenorrhea in women age 40 and younger with colorectal cancer.

Andrea Cercek; Diane Lauren Reidy; Leonard Saltz


Journal of Clinical Oncology | 2010

The role of octreotide imaging in detecting neuroendocrine tumors (NETs) in 2010: Do we still need it?

Leonard Saltz; Marc J. Gollub; Diane Lauren Reidy


Journal of Clinical Oncology | 2010

Surgical cytoreduction in patients with colorectal peritoneal carcinomatosis treated with contemporary chemotherapy.

V. G. Gava; Diane Lauren Reidy; P. Paty; Leonard Saltz; K. Y. Chung; Martin R. Weiser; Larissa K. Temple; Neil Howard Segal; L. F. Moreira; Garrett M. Nash


Journal of Clinical Oncology | 2018

Multicenter phase 2 study of nintedanib in patients (pts) with advanced progressing carcinoid tumors.

Renuka Iyer; Bhavana Konda; Dwight Owen; Kristopher Attwood; Suman Sarker; Sheryl-Ann Suffren; John Wilton; Robert Bies; Danielle Casucci; Diane Lauren Reidy; Manisha H. Shah


Journal of Clinical Oncology | 2018

Developing a telemedicine triage system to manage patient flow at a high volume cancer center urgent care.

Christian Otto; Diane Lauren Reidy; Stutman Robin; Kara Sutton; Erika Dugan; Lee Erickson; Lori Roland-Plonski; Jason Napoli; Danny Joseph; Jeffrey S. Groeger


Journal of Clinical Oncology | 2018

High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing.

Omobolaji Oyekunle Akala; Virginia Kelly; Vivian E. Strong; Anuradha Gopalan; Diane Lauren Reidy; Nitya Prabhakar Raj

Collaboration


Dive into the Diane Lauren Reidy's collaboration.

Top Co-Authors

Avatar

Leonard Saltz

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Andrea Cercek

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Larissa K. Temple

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Martin R. Weiser

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

P. Paty

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Abigail Baldwin

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Garrett M. Nash

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Jose G. Guillem

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Karyn A. Goodman

University of Colorado Denver

View shared research outputs
Researchain Logo
Decentralizing Knowledge